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In vertebrates,b cells are aggregated in the form
of pancreatic islets. Within these islets, commu-
nication between b cells inhibits basal insulin
secretion and enhances glucose-stimulated in-
sulin secretion, thus contributing to glucose ho-
meostasis during fasting and feeding. In the
search for the underlying molecular mecha-
nism, we have discovered that b cells commu-
nicate via ephrin-As and EphAs. We provide
evidence that ephrin-A5 is required for glucose-
stimulated insulin secretion. We further show
that EphA-ephrin-A-mediated b cell communi-
cation is bidirectional: EphA forward signaling
inhibits insulin secretion, whereas ephrin-A re-
verse signaling stimulates insulin secretion.
EphA forward signaling is downregulated in re-
sponse to glucose, which indicates that, under
basal conditions, b cells use EphA forward sig-
naling to suppress insulin secretion and that,
under stimulatory conditions, they shift to
ephrin-A reverse signaling to enhance insulin
secretion. Thus, we explain how b cell commu-
nication in pancreatic islets conversely affects
basal and glucose-stimulated insulin secretion
to improve glucose homeostasis.
INTRODUCTION
Pancreatic islets are essential for maintaining glucose
homeostasis, and defects in their ability to adequately
secrete insulin in response to glucose result in diabetes
mellitus (Bell and Polonsky, 2001). During embryonic de-
velopment, b cells initially develop as scattered cells (Gra-pin-Botton and Melton, 2000). However, as development
progresses, they aggregate with other b cells and endo-
crine cells to form pancreatic islets (Halban, 2004). While
glucose metabolism cell-autonomously triggers insulin
secretion (Maechler and Wollheim, 2001), communication
between b cells suppresses basal insulin secretion but en-
hances glucose-stimulated insulin secretion (Bosco et al.,
1989; Dahl et al., 1996; Halban et al., 1982; Hauge-Evans
et al., 1999; Hopcroft et al., 1985; Luther et al., 2006; Maes
and Pipeleers, 1984; Meda et al., 1990; Ravier et al., 2005;
Yamagata et al., 2002). Cell-cell communication therefore
ensures that b cells secrete low amounts of insulin during
times of starvation but sufficient amounts of insulin after
food uptake. However, the molecular mechanism that al-
lows b cell communication to suppress basal insulin se-
cretion and enhance glucose-stimulated insulin secretion
remains elusive.
Here we investigated EphA receptor tyrosine kinases
(RTK) and their ephrin-A ligands in pancreatic b cells since
EphAs and ephrin-As are involved in various aspects of
cell-cell communication (Himanen and Nikolov, 2003;
Pasquale, 2005). Ephs and ephrins are classified in A
and B subclasses, and most EphAs bind to ephrin-As,
while most EphBs bind to ephrin-Bs (Gale et al., 1996).
Both EphAs and ephrin-As are localized on the plasma
membrane and, therefore, require direct cell-cell contact
to bind and activate each other (Flanagan and Vanderhae-
ghen, 1998; Kullander and Klein, 2002; Pasquale, 2005).
The signaling pathway downstreamof the transmembrane
EphA RTKs is referred to as EphA forward signaling and
can be exogenously activated by ephrin-A-Fc-fusion pro-
teins (Figure 1A). The signaling pathway downstream of
the GPI-anchored ephrin-As is referred to as ephrin-A re-
verse signaling and can be exogenously activated by
EphA-Fc-fusion proteins (Figure 1A). In general, when
both signaling pathways are active, EphA-ephrin-A bidi-
rectional signaling takes place (Figure 1A). However, if
EphA forward signaling is inhibited by dephosphorylationCell 129, 359–370, April 20, 2007 ª2007 Elsevier Inc. 359
Figure 1. Expression and Localization of
Ephrin-As and EphAs in Pancreatic Islets
and MIN6 Cells
(A) shows a model of EphA-ephrin-A bidirec-
tional signaling between two adjacent b cells
and exogenous activation of ephrin-A reverse
signaling (green) and EphA forward signaling
(red) by EphA5-Fc- and ephrin-A5-Fc-fusion
proteins, respectively. Circled P represents
tyrosine phosphorylation.
(B) RT-PCR products for ephrin-A1 to -A5 and
EphA1 to -A8 are shown, performed with
mRNA isolated from mouse islets and mouse
insulinoma cells (MIN6). Only the upper
EphA4 band represents amplified EphA4 se-
quence, whereas both EphA5 bands represent
identical EphA5 sequences.
(C–F) Confocal images ofmouse pancreas sec-
tions show an islet surrounded by exocrine
pancreatic tissue. Sections were stained with
(C) anti-ephrin-A5 antibody, (D) EphA5-Fc that
binds to ephrin-As, (E) anti-EphA5 antibody,
and (F) ephrin-A5-Fc that binds to EphAs.
Scale bars are 50 mm.
(G–I) Confocal images of a group of MIN6 cells stained for ephrin-As and EphA5 cytoplasmic domain are shown. (G) shows low magnification and (H)
and (I) show high magnification of regions in (G). (H) shows contact region between two MIN6 cells with EphA-ephrin-A colocalization (white arrow-
head) and (I) shows free surfaces of MIN6 cells with no colocalization between ephrin-As (green arrowheads) and EphA5 (red arrowheads).
Scale bars in (G) are 10 mm and in (H) and (I) are 2 mm.of EphA receptors or, alternatively, truncation of their cy-
toplasmic parts, ephrin-A reverse signaling occurs without
kinase-dependent EphA forward signaling (Holmberg
et al., 2000; Parri et al., 2005; Shintani et al., 2006).
In this study, we demonstrate that b cells communicate
with each other via EphAs and ephrin-As. We show that
EphA forward signaling inhibits basal insulin secretion. In
contrast, glucose stimulation attenuates EphA forward
signaling by dephosphorylation of EphAs. This allows pre-
dominant ephrin-A reverse signaling, which enhances in-
sulin secretion. Our study on pancreatic islets therefore
shows that interacting cells coexpressing EphAs and eph-
rin-As can switch between two opposite states in re-
sponse to a stimulus. This mechanism enables pancreatic
islets to switch from low levels of insulin secretion to high
levels of insulin secretion upon glucose stimulation.
RESULTS
Ephrin-A and EphA Expression in Mouse and Human
Pancreatic Islets
We investigated the presence of Ephs and ephrins in pan-
creatic islets as possible candidate molecules involved in
cell-cell communication (Figure 1A). First, we detected
similar transcription of ephrin-As and EphAs in islets and
mouse insulinoma cells, MIN6 (Figure 1B). We also de-
tected expression of ephrin-Bs and EphBs (data not
shown) but focused on ephrin-As and EphAs due to their
strong abundance and similar expression in both islets
and MIN6 cells.360 Cell 129, 359–370, April 20, 2007 ª2007 Elsevier Inc.Immunostaining mouse pancreas sections showed co-
expression of ephrin-A5 and EphA5 proteins in islets, and
this expression was stronger in the islets than in the sur-
rounding exocrine tissue (Figures 1C and 1E). A similar ex-
pression was observed in the human pancreas (Figures
S1A–S1F). Other ephrin-As and EphAs, such as ephrin-
A1 and EphA7, were also expressed in mouse pancreatic
islets (Figures S2A and S2B).
Next we stained mouse pancreas sections with EphA5-
Fc- and ephrin-A5-Fc-fusion proteins, which bind with dif-
ferent affinity to virtually all ephrin-As and EphAs, respec-
tively (Figure 1A; Flanagan and Vanderhaeghen, 1998).
The staining showed that islet ephrin-As bind to EphA5
(Figure 1D) and that islet EphAs bind to ephrin-A5
(Figure 1F).
EphA5 and ephrin-As colocalized in regions where
MIN6 cells were in contact with each other (Figures 1G
and 1H). In line with the findings that EphAs and ephrin-As
segregate in motor neurons (Marquardt et al., 2005)
and that several transmembrane proteins also segregate
in insulinoma cells (Uhles et al., 2003), we observed little
colocalization of EphA5 and ephrin-As on the free sur-
faces of MIN6 cells (Figure 1I). Moreover, based on the
EphA5-Fc and ephrin-A5-Fc staining of nonpermeabilized
MIN6 cells, we found that ephrin-As were more strongly
localized to the plasma membrane compared to the
EphAs (Figures S3A andS3B). Conversely, EphAs strongly
localized to insulin secretory granules (Figure S3D),
whereas ephrin-As did not (Figure S3C).
These results show that EphAs and ephrin-As are co-
expressed in b cells and suggest that EphA-ephrin-A
Figure 2. Ephrin-A5 Is Required for Glucose-Stimulated Insulin Secretion
(A) Insulin secretion from male control and ephrin-A5/ islets at 2 mM glucose (white columns) and 25 mM glucose (black columns) is shown.
Secreted insulin is normalized to insulin content and total protein content. D indicates the difference between basal and glucose-stimulated insulin
secretion. n = 3 experiments.
(B) Insulin content of islets isolated frommale control mice and ephrin-A5/mice is presented as percent of total protein content. n = 3 experiments.
(C) Glucose-tolerance tests of control and ephrin-A5/ mice are shown. n = 7 male mice each.
(D) and (E) show EphA5-Fc immunostaining (green) of MIN6 cells transfected with (D) control siRNA and (E) ephrin-A5 siRNA 2. Cell nuclei are stained
with DAPI (blue). Scale bars are 20 mm.
(F) Insulin secretion is shown from MIN6 cells transfected with control siRNA, ephrin-A5 siRNA 1, or ephrin-A5 siRNA 2 or cotransfected with ephrin-
A5 siRNA 2 and ephrin-A5 cDNA without the targeted 30-UTR (= rescue experiment). White columns indicate 2 mM glucose, and black columns in-
dicate 25 mM glucose. Secreted insulin is normalized to insulin content and total protein content. n = 6 experiments.
*p < 0.05. All values are means ± SD.bidirectional signaling may take place between adjacent
b cells (Figure 1A).
Ephrin-A5 Is Required for Glucose-Stimulated
Insulin Secretion
To investigate whether ephrin-A5, a possible participant in
bidirectional signaling between b cells, was required for
insulin secretion, we compared control islets with eph-
rin-A5-deficient islets (ephrin-A5/) (Figures 2A and 2B).
In comparison with control islets, ephrin-A5/ islets had
a significantly reduced glucose-stimulated insulin secre-
tion (compare black columns in Figure 2A), showing that
ephrin-A5 is required for normal b cell insulin secretory re-
sponse to glucose (compare Ds in Figure 2A). In contrast,
we did not detect any differences in the insulin content be-
tween control and ephrin-A5/ islets (Figure 2B), thus ex-
cluding an effect of ephrin-A5 on insulin production. In line
with the insulin-secretion defects (Figure 2A), we also de-
tected impaired glucose tolerance in ephrin-A5-deficient
mice (Figure 2C).
To rule out the possibility that the observed defects
were due to changes in non-b cells, which are also present
in islets, we knocked down ephrin-A5 in MIN6 cells (Fig-ures 2D and 2E), a frequently usedmodel for b cells (Miya-
zaki et al., 1990). We noticed that ephrin-A5 knockdown
led to significantly increased basal insulin secretion (white
columns in Figure 2F) as well as significantly reduced
glucose-stimulated insulin secretion (black columns in
Figure 2F). These results show that ephrin-A5 is involved
in suppression of basal insulin secretion and is required
for glucose-stimulated insulin secretion. The data further
show that ephrin-A5 plays a role in glucose-stimulated in-
sulin secretion, which is not substituted by any of the other
ephrin-As expressed in pancreatic b cells.
Opposite Effects of EphA5-Fc and Ephrin-A5-Fc
on Insulin Secretion
To uncover the underlying molecular mechanism, we first
investigated the effects of ephrin-A reverse signaling and
EphA forward signaling on insulin secretion (Figure 3). We
used EphA5-Fc to stimulate ephrin-A reverse signaling
and ephrin-A5-Fc to stimulate EphA forward signaling
(Figures 3A and 3B), and we used Fc fragment as control
(Figures S4A and S4B). We showed that EphA5-Fc signif-
icantly increased basal and glucose-stimulated insulin se-
cretion (compare EphA5-Fc with Fc in Figure 3A), whereasCell 129, 359–370, April 20, 2007 ª2007 Elsevier Inc. 361
Figure 3. Opposite Effects of EphA5-Fc
and Ephrin-A5-Fc on Insulin Secretion
(A) and (B) show insulin secretion from (A)
mouse pancreatic islets and (B) MIN6 cells
treated with Fc (as control), EphA5-Fc (to acti-
vate ephrin-A reverse signaling), and ephrin-
A5-Fc (to activate EphA forward signaling) at
2 mM glucose (white columns) and 25 mM glu-
cose (black columns). Insulin secretion is nor-
malized to insulin content and total protein con-
tent. n = 3 experiments.
(C) Glucose-stimulated insulin secretion from
MIN6 cells at high cell density (lower left image)
and low cell density (lower right image) is
shown after treatment with Fc (white columns)
or EphA5-Fc (black columns). n = 4 experi-
ments. Scale bars are 100 mm.
(D) Basal insulin secretion from MIN6 cells at
high cell density and low cell density after treat-
ment with Fc (white columns) or ephrin-A5-Fc
(black columns) is shown. n = 3 experiments.
Scale bars are 100 mm.
(E) Detection of tyrosine-phosphorylated
EphA5 (PY) and total EphA5 in western blots af-
ter EphA5 immunoprecipitation from lysates of
MIN6 cells that were grown at high and low cell
density and kept under basal conditions for 1 hr
with Fc or with ephrin-A5-Fc is shown.
(F) EphA5 tyrosine phosphorylation, relative to
total EphA5 protein, is shown in a histogram
for the experiment shown in (E). n = 2 experi-
ments.
*p < 0.05. All values are means ± SD.ephrin-A5-Fc significantly decreased glucose-stimulated
insulin secretion from mouse pancreatic islets (compare
ephrin-A5-Fc with Fc in Figure 3A).
Islets consist mainly of b cells but also harbor other cell
types that might have been affected in these experiments.
Therefore, we tested the role of ephrin-A reverse signaling
and EphA forward signaling in MIN6 cells and obtained
similar results (Figure 3B). Moreover, EphA7-Fc and eph-
rin-A1-Fc also conversely affected glucose-stimulated in-
sulin secretion (Figure S2C). Finally, we showed that
EphA5-Fc increased, and that ephrin-A5-Fc suppressed,
glucose-stimulated insulin secretion from human pancre-
atic islets (Figure S1G).362 Cell 129, 359–370, April 20, 2007 ª2007 Elsevier Inc.EphA5-Fc Partially Rescues Glucose-Stimulated
Insulin Secretion in Cells with Reduced
Cell-Cell Contact
Glucose-stimulated insulin secretion is decreased in situ-
ations of reduced b cell communication (Luther et al.,
2006; Maes and Pipeleers, 1984; Meda et al., 1990).
Therefore we asked whether EphA5-Fc restored glucose-
stimulated insulin secretion in MIN6 cells with reduced
cell-cell contact (Figure 3C). We first showed that non-
confluent cells (‘‘low cell density’’) had less glucose-
stimulated insulin secretion compared to confluent cells
(‘‘high cell density’’; compare white columns in Figure 3C).
We then showed that EphA5-Fc partially restored
glucose-stimulated insulin secretion in these cells (com-
pare last two columns in Figure 3C), suggesting that en-
dogenous ephrin-A reverse signaling is required for en-
hancing glucose-stimulated insulin secretion.
Ephrin-A5-Fc Fully Rescues Suppression of Basal
Insulin Secretion in Cells with Reduced
Cell-Cell Contact
We noticed that ephrin-A5-Fc decreased glucose-stimu-
lated insulin secretion but did not decrease basal insulin
secretion from islets and MIN6 cells (Figures 3A and 3B).
We hypothesized that basal insulin secretion could not
be decreased because it was maximally suppressed by
endogenous EphA-ephrin-A interactions.
As shown in Figure 3D, nonconfluent MIN6 cells had
significantly enhanced basal insulin secretion (compare
white columns) aswell as reduced EphA5 phosphorylation
levels compared to confluent cells (Figure 3E; compare
white columns in Figure 3F). Importantly, ephrin-A5-Fc
decreased basal insulin secretion in these cells to a
level characteristic of confluent MIN6 cells (compare last
two columns in Figure 3D). Consistent with the idea that
this inhibition was due to exogenous activation of EphA
forward signaling, ephrin-A5-Fc significantly increased
EphA5 phosphorylation levels in the nonconfluent cells
(Figure 3E; compare last two columns in Figure 3F). These
results therefore suggest that endogenous EphA forward
signaling is required for inhibiting basal insulin secretion.
Ephrin-A Reverse Signaling Stimulates
Insulin Secretion
The previous experiments strongly suggested that ephrin-
A reverse signaling enhanced insulin secretion (Figure 3).
Here we used single primary b cells to stimulate ephrin-A
reverse signaling with EphA5-Fc, without simultaneously
affecting endogenous EphA forward signaling (Figure 4A).
We expressed GFP-tagged insulin in primary mouse
b cells and stimulated these cells with glucose in the pres-
ence or absence of EphA5-Fc (Figure 4A). We then moni-
tored the secretory events in single b cells by using total
internal reflection-fluorescence microscopy (TIR-FM;
Movies S1 and S2). As shown in Figure 4B, EphA5-Fc
treatment significantly increased fusion events of newly
recruited insulin secretory granules (white columns).
Glucose-stimulated insulin secretion, in response to a
sudden increase in glucose concentration, follows a bi-
phasic time course consisting of a rapid first phase
followed by a sustained second phase (Rorsman and
Renstrom, 2003). We found that EphA5-Fc increased the
number of secretory events during both phases of insulin
secretion with a stronger effect on the second phase
(compare Figures 4C and 4D). We conclude that ephrin-
A reverse signaling stimulates insulin secretion.
EphA Forward Signaling Suppresses
Insulin Secretion
The experiments, shown in Figure 3, strongly suggested
that EphA forward signaling suppressed insulin secretion.Here we used TIR-FM of single ephrin-A5-Fc-treated pri-
mary b cells to provide evidence of a suppressive effect
of EphA forward signaling (Figure 4E; Movies S3 and
S4). As shown in Figure 4F, ephrin-A5-Fc significantly re-
duced the number of fusion events of newly recruited insu-
lin secretory granules (white columns). In addition, ephrin-
A5-Fc reduced the number of secretory events during
both phases of insulin secretion with a stronger effect on
the second phase (compare Figures 4G and 4H).
As additional evidence of an inhibitory effect of EphA
forward signaling on insulin secretion, a dominant-
negative EphA5 protein (DN-EphA5) lacking its cytoplas-
mic domain was expressed in MIN6 cells (Figure S5A).
This DN-EphA5 binds to ephrin-As and is expected to in-
duce ephrin-A reverse signaling and inhibit EphA forward
signaling (Gao et al., 1998). In contrast, overexpression of
a full-length EphA5 protein (WT EphA5) is expected to in-
duce both ephrin-A reverse signaling and EphA forward
signaling (Figure S5B). In support of an inhibitory effect
of EphA forward signaling, we found that DN-EphA5 in-
creased basal and glucose-stimulated insulin secretion,
whereas WT EphA5 overexpression decreased glucose-
stimulated insulin secretion in confluent MIN6 cells
(Figure S5C). We conclude that EphA forward signaling
suppresses insulin secretion.
Downstream Targets of EphA-Ephrin-A Signaling
and Their Impact on Insulin Secretion
It has been shown that destabilization of F-actin enhances
insulin secretion, whereas its stabilization inhibits insulin
secretion (Orci et al., 1972). This led to the hypothesis
that dense cortical F-actin limits access of insulin secre-
tory granules to the plasma membrane. However, since
complete F-actin depolymerization inhibits glucose-stim-
ulated insulin secretion (Li et al., 1994), certain actin fila-
ments appear to be required for the secretory process.
Because ephrin-A reverse signaling and EphA forward
signaling, were shown to rearrange F-actin in several cell
types (Marquardt et al., 2005; Parri et al., 2005), we tested
whether EphA5-Fc and ephrin-A5-Fc also changed the F-
actin state of mouse insulinoma cells (Figures 5A–5E). We
found that EphA5-Fc resulted in F-actin rearrangements
with a subtle decrease in F-actin intensity under basal
conditions (compare Figures 5A and 5B), consistent with
its stimulatory effect on insulin secretion. In contrast, eph-
rin-A5-Fc increased F-actin polymerization in nonconflu-
ent clusters of MIN6 cells under basal and stimulatory
conditions (compare Figures 5C and 5D), consistent with
its inhibitory effect on insulin secretion.
EphAs modulate activity of Rac1, a Rho-GTPase in-
volved in F-actin remodeling and endocytosis (Marston
et al., 2003; Shamah et al., 2001; Zhuang et al., 2007; Zim-
mer et al., 2003). Since Rac1 is also involved in glucose-
stimulated insulin secretion (Kowluru and Veluthakal,
2005; Li et al., 2004), we investigated whether EphA5-Fc
and ephrin-A5-Fc modulated Rac1 activity in confluent
MIN6 cells. In line with previous reports (Kowluru and
Veluthakal, 2005; Li et al., 2004), glucose stimulationCell 129, 359–370, April 20, 2007 ª2007 Elsevier Inc. 363
Figure 4. Opposite Effects of Ephrin-A
Reverse Signaling and EphA Forward
Signaling on Insulin Secretory Granule
Fusion
(A) Model shows activation of ephrin-A reverse
signaling by EphA5-Fc in a single insulin-
GFP-expressing mouse pancreatic b cell. Total
internal reflection-fluorescence microscopy
(TIR-FM) was used to detect fusion of insulin
secretory granules (SG) with the plasma
membrane.
(B) Histogram shows all secretory fusion events
in single b cells detected during 16 min treat-
ment with 22 mM glucose in the absence (con-
trol) or presence of EphA5-Fc. Fusion events of
previously docked SG (black columns) and
newly recruited SG (white columns) were nor-
malized to the cell area. n = 5–7 cells each.
(C) and (D) show time course of the fusion
events shown in (B). Cells were treated with
22 mM glucose in the absence (C) or presence
(D) of EphA5-Fc.
(E) Model shows activation of EphA forward
signaling by ephrin-A5-Fc in a single insulin-
GFP-expressing mouse pancreatic b cell. TIR-
FM was used to detect fusion of SG with the
plasma membrane.
(F) Histogram showing all secretory fusion
events in single b cells detected during 16
min treatment with 22 mM glucose in the ab-
sence (control) or presence of ephrin-A5-Fc.
n = 20–21 cells each.
(G) and (H) show time course of fusion events
shown in (F). Cells were treated with 22 mM
glucose in the absence (G) or presence (H) of
ephrin-A5-Fc. *p < 0.05. All values are
means ± SEM.significantly enhanced Rac1 activity (Fc; Figures 5F and
5G). Consistent with its stimulatory effects on insulin se-
cretion, we found that EphA5-Fc stimulated Rac1 activity
(compare Fc with EphA5-Fc in Figure 5G), whereas, con-
sistent with its inhibitory effect on insulin secretion, ephrin-
A5-Fc inhibited Rac1 activity (compare Fc with ephrin-
A5-Fc in Figure 5G). In addition, both EphA5-Fc and
ephrin-A5-Fc required Rac1 activity for their effects on
glucose-stimulated insulin secretion (compare DN-Rac1
with empty vector in Figure 5H).
Since Eph-ephrin signaling was shown to affect con-
nexin localization and gap junction communication (Davy
et al., 2006; Mellitzer et al., 1999), we also investigated
whether connexin-36, the gap junction protein of b cells
(Ravier et al., 2005), was required for the effects of Eph-
ephrin signaling on insulin secretion (Figure S6). We
showed that the stimulatory effect of EphA5-Fc required
connexin-36 (compare Fc with EphA5-Fc in Figure S6C),364 Cell 129, 359–370, April 20, 2007 ª2007 Elsevier Inc.whereas an inhibitory effect of ephrin-A5-Fc was still de-
tected in the absence of this gap junction protein (com-
pare Fc with ephrin-A5-Fc in Figure S6C).
Taken together, these results show that EphA-ephrin-A-
signaling events affect several b cell components required
for regulating insulin secretion: F-actin, Rac1, and con-
nexin-36.
Glucose-Induced Dephosphorylation of EphA5
We then investigated the hypotheses that, under basal
conditions, EphA forward signaling was active in order
to suppress insulin secretion (Figure 6A) and that glucose
stimulation attenuated EphA forward signaling by EphA
dephosphorylation, thus allowing predominance of
ephrin-A reverse signaling with a stimulatory outcome
for insulin secretion (Figure 6B).
Supporting this hypothesis, EphA5 phosphorylation
levels were higher at a low glucose concentration (2 mM)
Figure 5. Opposite Effects of EphA5-Fc and Ephrin-A5-Fc on F-Actin and Rac1 Activity
(A–D) F-actin staining ofMIN6 cells treated for 10minwith (A) 2mMglucose and Fc, (B) 2mMglucose and EphA5-Fc, (C) 25mMglucose and Fc, (D) 25
mM glucose and ephrin-A5-Fc is shown. Scale bars are 20 mm.
(E) Quantification of F-actin fluorescence intensity in MIN6 cells treated for 10 min with Fc, EphA5-Fc, and ephrin-A5-Fc at 2 mM glucose (white col-
umns) and 25 mM glucose (black columns) is shown. n = 10 images of each coverslip (n = 3) were quantified.
(F) Detection of active Rac1-GTP (upper bands) and total Rac1 (lower bands) in western blots is shown. Cells were treated for 10 min with Fc, EphA5-
Fc, and ephrin-A5-Fc at 2 mM glucose and 25 mM glucose.
(G) Corresponding histograms of Rac1 activity, relative to total Rac1 protein, are shown. n = 3 experiments.
(H) Insulin secretion from MIN6 cells transfected with empty vector, DN-Rac1, and WT Rac1 after treatment with Fc, EphA5-Fc, and ephrin-A5-Fc at
2 mM glucose (white columns) and 25 mM glucose (black columns) is shown. n = 3 experiments.
*p < 0.05. All values are means ± SD.compared to all depicted time points after glucose stimu-
lation (25 mM; Figures 6C and 6D). In islets, the presence
of phosphorylated EphA5 decreased shortly after glucose
stimulation (Figure 6C). However, when the islets were
brought back to low glucose concentration, EphA5 phos-
phorylation reached basal levels again (Figure 6C).
As with islets, the amount of phosphorylated EphA5 in
MIN6 cells decreased shortly after glucose stimulation
(Figure 6D), and bringing back glucose-stimulated MIN6
cells to a low glucose concentration fully restored basal
EphA5 phosphorylation (Figure 6D). We also noticed that
ephrin-A5-Fc significantly increased EphA5 phosphoryla-tion in nonconfluent MIN6 cells (Figures 3E, 3F, 6E, and
6F). Thus, EphA5 phosphorylation correlates with inhibi-
tion of insulin secretion.
To demonstrate that EphA5 was not the only EphA to be
dephosphorylated in b cells, we performed experiments
with other members of the EphA-receptor family and ob-
served a similar dephosphorylation upon glucose stimula-
tion (data not shown). We also showed that 10 mM perox-
ovanadate (PV), a PTP inhibitor, effectively prevented
glucose-induced EphA5 dephosphorylation (Figure 6G).
Therefore, these results suggest that, under basal condi-
tions, EphA forward signaling is active in order to inhibitCell 129, 359–370, April 20, 2007 ª2007 Elsevier Inc. 365
Figure 6. Glucose-Induced Dephosphor-
ylation of EphA5
(A and B) Model showing how glucose changes
the outcome of EphA-ephrin-A bidirectional
signaling. (A) At low glucose concentration,
EphA forward signaling is active. (B) Upon glu-
cose stimulation, EphA forward signaling is at-
tenuated by EphA dephosphorylation involving
a protein tyrosine phosphatase (PTP) activity.
(C–G) Detection of tyrosine-phosphorylated
EphA5 (PY) and total EphA5 in western blots af-
ter immunoprecipitation of EphA5 from cell ly-
sates is shown. The EphA5 phosphorylation
level relative to total EphA5 protein is shown
in histograms. 2 mM glucose (white columns)
and 25mMglucose (black columns) are shown.
(C) Pancreatic islets were treated with 2 mM
glucose for 30 min, then with 25 mM glucose
for 5, 10, and 30 min; this was followed by
a switch from 25 mM to 2 mM glucose for
30 min. Islets treated with ephrin-A5-Fc for
10 min at 2 mM and 25 mM glucose are also
shown.
(D) MIN6 cells were treated with 2 mM glucose
for 30min and thenwith 25mMglucose for 2, 5,
10, and 30 min, followed by a switch from
25 mM to 2 mM glucose for 30 min.
(E–G) MIN6 cells were treated for 5 min with (E)
Fc, (F) ephrin-A5-Fc, and (G) Fc + 10 mM PV (to
inhibit the glucose-induced EphA5 dephos-
phorylation) at 2 mM and 25 mM glucose.
n = 2 experiments. *p < 0.05. All values are
means ± SD.insulin secretion (Figure 6A) and that, upon glucose stim-
ulation, EphA forward signaling is downregulated by de-
phosphorylation (Figure 6B).
EphA5 Dephosphorylation Is Required
for Glucose-Stimulated Insulin Secretion
It was previously shown that treatment of islets with 10 mM
PV strongly reduced glucose-stimulated insulin secretion
(Gogg et al., 2001). Based on our experiments, we hypoth-
esized that PV was inhibitory, in part, by preventing glu-
cose-induced EphA dephosphorylation (Figure 7A). After
confirming in islets and MIN6 cells that 10 mM PV sup-
pressed glucose-stimulated insulin secretion (Figures 7D
and 7E), we showed that insulin secretion could be par-
tially rescued in PV-treated MIN6 cells by overexpression
of DN-EphA5 (Figure 7B; compare Empty vector/PV with
DN-EphA5/PV in Figure 7E). In contrast, WT EphA5 re-
duced glucose-stimulated insulin secretion in PV-treated
MIN6 cells even further (Figure 7C; compare empty vec-
tor/PV with WT EphA5/PV in Figure 7E). We conclude366 Cell 129, 359–370, April 20, 2007 ª2007 Elsevier Inc.that downregulation of EphA forward signaling is essential
for glucose-stimulated insulin secretion.
DISCUSSION
The Mystery of b Cell Communication
A few dozen to a few thousand b cells form the core of
pancreatic islets (Halban, 2004). The presence of islets
and b cell aggregates in all vertebrates underlines the im-
portance of b cell-b cell interactions. Various experiments
over the last three decades have shown that b cell com-
munication inhibits basal insulin secretion and enhances
glucose-stimulated insulin secretion; therefore, it contrib-
utes to glucose homeostasis (Bosco et al., 1989; Dahl
et al., 1996; Halban et al., 1982; Hauge-Evans et al.,
1999; Hopcroft et al., 1985; Luther et al., 2006; Maes and
Pipeleers, 1984; Meda et al., 1990; Ravier et al., 2005; Ya-
magata et al., 2002). However, it remained an open ques-
tion how b cell communication exerted opposite effects on
Figure 7. EphADephosphorylation Is Re-
quired for Insulin Secretion
(A) Model shows that PV blocks a PTP activity,
which normally dephosphorylates EphAs at
high glucose concentration.
(B) Model shows that overexpression of EphA5
that is lacking its cytoplasmic domain (DN-
EphA5) rescues inhibition of EphA forward sig-
naling in PV-treated cells at high glucose con-
centration.
(C) Model shows that overexpression of WT
EphA5 potentiates EphA forward signaling in
PV-treated cells.
(D) Insulin secretion from mouse pancreatic is-
lets treated with Fc in the absence or presence
of 10 mM PV at 2 mM glucose (white columns)
and 25 mM glucose (black columns) is shown.
Secreted insulin is normalized to insulin con-
tent and total protein content. n = 3 experi-
ments. *p < 0.05. All values are means ± SD.
(E) shows insulin secretion from MIN6 cells
transfected with an empty vector, DN-EphA5,
or WT EphA5 in the absence or presence of
10 mM PV at 2 mM glucose (white columns)
and 25 mM glucose (black columns). Secreted
insulin is normalized to insulin content and total
protein content. n = 2 experiments. *p < 0.05.
All values are means ± SD.
(F and G) Model. (F) At low glucose concentra-
tion, interactions between EphAs (red) and
ephrin-As (green) on adjacent b cell plasma
membranes suppress insulin secretion. (G)
Upon glucose stimulation, a PTP activity de-
phosphorylates EphAs, and EphA-ephrin-A in-
teractions stimulate insulin secretion.insulin secretion that were dependent on glucose concen-
trations.
EphA-Ephrin-A-Mediated Cell-Cell Communication
and Its Effects on Insulin Secretion
Here, we discovered that b cells communicate with each
other via ephrin-As and EphAs. Based on our results, we
propose a model that explains for the first time how b
cell communication exerts opposite effects on insulin se-
cretion, dependent on glucose concentrations: at a low
glucose concentration (Figure 7F), EphA forward signaling
is predominant and suppresses insulin secretion. In con-
trast, at a high glucose concentration (Figure 7G), EphAs
are dephosphorylated via PTP activity. This dephosphor-
ylation shifts the balance from EphA forward signaling to-
ward ephrin-A reverse signaling, which enhances insulin
secretion (Figure 7G).
We showed that EphAs and ephrin-As are segregated
within mouse insulinoma cells and are able to functionally
interact with the ephrin-As and EphAs of adjacent cells.
We discovered that a large portion of EphAs was localized
on insulin secretory granules, suggesting that EphAs ac-
cess the b cell plasma membrane when insulin is releasedwith different outcomes that are dependent on glucose
concentration. At low glucose concentrations, EphAs are
phosphorylated, and they inhibit further insulin secretion
(negative feedback; Figure 7F). In contrast, at high glucose
concentrations, EphAs are dephosphorylated and, there-
fore, support insulin secretion via ephrin-A reverse signal-
ing (positive feedback; Figure 7G).
The proposed mechanism therefore explains how b
cell communication suppresses basal insulin secretion
(Figure 7F) and, at the same time, enhances glucose-stim-
ulated secretion (Figure 7G).
A New Role of EphA and Ephrin-A Coexpression
In many cell types, EphA forward signaling and ephrin-A
reverse signaling mediate opposite effects (Marquardt
et al., 2005), and cells coexpressing EphAs and ephrin-
As exist in many tissues (Carvalho et al., 2006; Marquardt
et al., 2005). This raises the fundamental question about
the role of their coexistence. Two hypotheses have been
recently proposed (Carvalho et al., 2006; Marquardt et al.,
2005). According to one hypothesis, EphAs and ephrin-As
are segregated in different plasma membrane domains,
from which they interact in trans with the ephrin-As andCell 129, 359–370, April 20, 2007 ª2007 Elsevier Inc. 367
EphAs of adjacent cells, thus resulting in signaling events
(Marquardt et al., 2005). According to the other hypothe-
sis, EphAs and ephrin-As are not segregated, but they in-
teract in cis, thus preventing trans-interactions and signal-
ing (Carvalho et al., 2006).
For pancreatic b cells, we show that EphAs and ephrin-
As interact in trans and that glucose stimulationmodulates
EphA forward signaling. Firstly, EphAs and ephrin-As are
segregated since EphAs are present on insulin secretory
granules, whereas ephrin-As are absent from these exo-
cytotic vesicles. Secondly, EphA5 phosphorylation in-
creases with increasing cell-cell contacts, suggesting
that endogenous EphA5 interacts in trans with endoge-
nous ephrin-As. Finally, ephrin-A5-Fc significantly in-
creases EphA5 phosphorylation in b cells, showing that
EphA5 can interact with ephrin-A5 in trans.
Based on our results, we propose that coexpression of
EphAs and ephrin-As regulates the physiologic insulin se-
cretory response of b cells to glucose. Interestingly, many
synapses express juxtaposed Eph receptors and ephrins
(Armstrong et al., 2006; Dalva et al., 2000; Grunwald
et al., 2001; Henderson et al., 2001; Murai and Pasquale,
2004), and it is possible that secretory events in the
synapse are modulated by EphA-ephrin-A bidirectional
signaling in a similar way as insulin secretion in pancreatic
islets.
Two Pathways to Stimulate Insulin Secretion
In this study, we showed that either inhibition of EphA for-
ward signaling or activation of ephrin-A reverse signaling
increases glucose-stimulated insulin secretion. The
EphA forward-signaling pathway involves the transmem-
brane EphA5 RTK. In contrast, the ephrin-A reverse sig-
naling pathway involves the GPI-linked ephrin-A5. Since
ephrin-A5 is localized on the outer leaflet of the plasma
membrane, it cannot transmit signals on its own and prob-
ably depends on transmembrane proteins for signal trans-
mission. Thus, the ephrin-A reverse-signaling pathway
may be similar to the signaling pathway of other GPI-
linked proteins, such as GDNF receptors (GFRa) that
transmit signals into the cell by modulating the activity of
associated transmembrane proteins (Paratcha et al.,
2003).
In the future, it will be necessary to identify the proper-
ties of all Ephs and ephrins expressed in b cells in order
to design strategies for improving glucose-stimulated in-
sulin secretion in humans. For example, EphA7-Fcmoder-
ately, but selectively, increases glucose-stimulated insulin
secretion rather than basal insulin secretion, possibly due
to its special affinity for the ephrin-As expressed in b cells.
Thus, drugsmay be developed that target the Eph-ephrin-
signaling pathways in b cells and that may circumvent the
hypoglycemic side effects of most drugs currently used
for diabetes treatment. This study therefore uncovered
two new pathways in b cells that can now be exploited
for developing novel treatments of type II diabetes, a dis-
ease currently affecting 200 million people worldwide.368 Cell 129, 359–370, April 20, 2007 ª2007 Elsevier Inc.EXPERIMENTAL PROCEDURES
Cell Culture and Transfection Procedure
MIN6 cells (Miyazaki et al., 1990) were electroporated via nucleofec-
tion (Amaxa) with pEGFP, pEGFP-wtEphA5 (Gao et al., 1998),
pEGFP-DN-EphA5 (Gao et al., 1998), pEGFP-ephrin-A5 (Wimmer-
Kleikamp et al., 2004), pEGFP-wtRac1, pEGFP-DN-Rac1 (Rac1N17),
and pcDNA-Cx36 constructs as well as siRNA against firefly luciferase
(control siRNA), ephrin-A5, and cx36.
Mouse Models, Pancreatic Islets, and Glucose Tolerance Test
Pancreatic islets were isolated from female NMRI mice. Exceptions
were the islets from ephrin-A5/ and control mice (Knoll et al.,
2001) as well as the islets used for TIR-FM, which were C57BL/6. All
mice used were 8 to 10 weeks old. Human pancreatic islets were iso-
lated from a perfused human pancreas by using a protocol approved
by the Ethical Research Committee of the Technical UniversityMedical
School Dresden and according to the law of the State of Saxony.
The glucose tolerance test was performed as previously described
(Lammert et al., 2003).
RT-PCR, siRNA Syntheses, and Real-Time RT-PCR
Total RNA was extracted fromMIN6 cells andmouse pancreatic islets,
transcribed into cDNA, and used for RT-PCR. All Ephs and ephrins
primers were initially tested on cDNA isolated from different embryonic
and adult mouse organs as positive controls.
Small interfering RNA against 30-UTR of ephrin-A5 and cx36 was
prepared as previously described (Nikolova et al., 2006), and knock-
down efficiencies were tested by using real-time RT-PCR. All primer
sequences are listed in Table S1.
Insulin Secretion from Pancreatic Islets and MIN6 Cells
For insulin secretion measurements, islets or MIN6 cells were starved
for 1 hr in Krebs Ringer Buffer (KRB) containing 2 mM glucose. After
starvation, medium was exchanged for the same buffer ± Fc-fusion
proteins to measure basal secretion or for KRB containing 25 mM glu-
cose ± Fc-fusion proteins to measure glucose-stimulated insulin se-
cretion during 1 hr incubation. Islets were continuously shaken (300–
500 rpm) to facilitate access of Fc-fusion proteins to islet b cells. The
amount of secreted insulin was measured in the medium, and islets
or MIN6 cells were subsequently dissolved in RIPA buffer to measure
insulin content and total protein content. Secreted insulin was normal-
ized to total insulin content and total protein content and presented as
percent of basal control insulin secretion. In all histograms, the first col-
umn represents the basal control (=100%). Secreted insulin and insulin
content were measured by using ultrasensitive rat insulin ELISA (Crys-
tal Chem.). The total protein content was measured by using BCA kit
(Molecular Probes). Fc-fusion proteins (R&D systems) and sodium
vanadate (Sigma) were used at concentrations of 4 mg/ml and
10 mM, respectively. To control for cell viability and proliferation during
1 hr insulin secretion assay, water-soluble tetrazolium (WST-1) re-
agent (Roche) and BrdU ELISA (Roche) were used, respectively
(Figure S4).
Confocal Light Microscopy and TIR-FM
1:100-diluted rabbit anti-EphA5, rabbit anti-EphA7, rabbit anti-ephrin-
A1 (Santa Cruz), goat anti-ephrin-A5 (R&D systems), guinea pig anti-
insulin (DAKO), and rabbit anti-connexin-36 antibodies (Invitrogen) as
well as 4 mg/ml Fc-fusion proteins (R&D systems) were used for stain-
ing of cells and fixed pancreas sections. Secondary antibodies were
conjugated with AlexaFluor488 (Molecular Probes) and with Cy5 (Dia-
nova). DAPI (Sigma) was used to stain cell nuclei. MIN6 cells were
treated with Fc-fusion proteins for 10 min, fixed, and stained with
1:500-diluted phalloidin-rhodamine (Molecular Probes). Confocal im-
ages were acquired by using a Zeiss confocal microscope. Intensities
were quantified by using ImageJ software (NIH).
The Olympus TIR-FM was used with a high-aperture objective lens
(Apo 1003 OHR; NA 1.65, Olympus). To monitor single insulin gran-
ules, adenovirus (insulin-GFP)-infected primary mouse b cells on
high-refractive-index glass were mounted in an open chamber and in-
cubated for 60 min at 37C in KRB containing 2.2 mM glucose (starva-
tion). Cells were preincubated for 15 min ± Fc-fusion proteins under
basal conditions, transferred to a thermostat-controlled stage (37C),
and stimulated by addition of 22 mM glucose-KRB ± 4 mg/ml EphA5-
Fc or ephrin-A5-Fc. Images were acquired every 300 ms and analyzed
by using Metamorph software (Molecular Devices).
Immunoprecipitation and Western Blot
MIN6 cell lysates and islet cell lysates containing 1 mg or 500 ng total
protein, respectively, were used for immunoprecipitation with rabbit
anti-EphA5 antibody (Santa Cruz) and protein-A beads (Amersham).
For pulldown experiments, a Rac1-activation StressXPress Kit (Bio-
mol) was used. For western blots, rabbit anti-EphA5 antibody (Santa
Cruz), mouse anti-PY antibody (Biomol) and rabbit anti-Rac1 antibody
(Santa Cruz) were used in combination with HRP-conjugated second-
ary antibodies (Dianova). Western blots were developed by using an
ECL system (Amersham). The intensities of EphA5 bands and Rac1
bands were normalized to the intensities of total EphA5 and total
Rac1, respectively, and presented as percent of basal control. The in-
tensities of the bands were quantified by using TotalLab software
(Stratagene).
Statistical Analyses
Statistical significance was determined by using Student’s t test with
two-tailed distribution and two-sample unequal variance. In all tests,
two groups with only one changed parameter were compared.
p values for all relevant comparisons are given in Table S2.
Supplemental Data
Supplemental Data include six figures, two tables, and fourmovies and
can be found with this article online at http://www.cell.com/cgi/
content/full/129/2/359/DC1/.
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